Confocal microscopy manufacturer Optiscan Imaging is looking to expand into the veterinary market with its microscopy imaging system with an initial focus on cancer detection in companion animals. The company has signed MOU with the University of Minnesota College of Veterinary Medicine to enable the development of clinical data for Optiscan’s digital confocal laser endomicroscopic…
Two projects backed by the Advanced Manufacturing Growth Centre have commercialised technology based on cosmic rays and hyperspectral imaging to make mining safer and more productive. In a statement on Tuesday, the not-for-profit organisation highlighted projects by Swinburne University spinout mDetect and ASX-listed EQ resources, both of which received backing from AMGC’s Commercialisation Fund. mDetect…
Confocal microscopy manufacturer Optiscan Imaging has completed the beta phase development of its cloud-connected telepathology platform developed in partnership with Prolucid Technologies. The development is a significant advancement in digital pathology, according to the company, enabling real-time, remote collaboration on patient imaging sessions. The platform utilises Optiscan’s confocal imaging technology to generate digital pathology data,…
Microscopic imaging technology company Optiscan Imaging has revealed an innovative new medical imaging device, InVue, which is designed to enable precision surgery through real-time digital pathology. Manufactured in Melbourne in partnership with industrial design firm Design + Industry, InVue is a significant milestone for the company, traditionally known for its confocal microscope devices. Optiscan CEO…
Optiscan Imaging has entered into a collaboration through a know-how agreement with Mayo Clinic in the US to develop a digital confocal laser endomicroscopic imaging system for use in robotic surgery. The collaboration combines Optiscan’s engineering expertise in digital endomicroscopic hardware and software development with Mayo Clinic’s know-how in robotic surgery and quality patient care,…
US technology company Keysight Technologies has taken a strategic stake worth $15.28 million in medical imaging company EMVision. In a statement on Thursday, EMVision said the investment represented a significant milestone, and would accelerate commercialisation of the portable brain scanner emu, its first product. Keysight will be issued 7,454,231 new ordinary shares at $2.05 per…
Brain imaging technology company EMVision Medical Devices has announced promising clinical trial results from a patient study of its haemorrhagic stroke detection algorithm. The algorithm, dubbed ‘blood or not’, is a critical part of the microwave imaging system the company is developing under a grant from the Australian Stroke Alliance, to be fitted to point…
Brain imaging company EMVision Medical Devices has announced receipt of a $1.75 million payment under the Modern Manufacturing Initiative (MMI) grant. EMVision was awarded a grant worth $5 million in non-dilutive funding in May 2022 from the previous federal government’s MMI. The funding under the initiative’s Translation stream is to assist establishing commercial production of…
